Huimin Wang - Jul 8, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Japan & Intercontinental
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Jul 8, 2022
Transactions value $: -$229,332
Form type: 4
Date filed: 7/8/2022, 06:21 PM
Previous filing: Jun 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$129K	+3.68K	+3.7%	$35.20	103K	Jul 8, 2022	Direct	F1
transaction	EW	Common Stock	Sale	-$359K	-3.68K	-3.57%	$97.60	99.4K	Jul 8, 2022	Direct	F1

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-3.68K	-12.5%	$0.00	25.7K	Jul 8, 2022	Common Stock	3.68K	$35.20	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.